Beijing Beilu Pharmaceutical Co.,Ltd.’s Net Profit Dropped 65.4% in First Three Quarters of 2022

Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陆药业股份有限公司) (300016.SZ) reported a net profit of 42.2 million yuan in the first three quarters of 2022, down 65.4% year-on-year.

Meanwhile, the company posted 557.3 million yuan in revenue, down 18.1% year-on-year.

At the end of the reporting period, it had 2.8 billion yuan in total assets and 845.1 million yuan in total liabilities, with a liability-to-asset ratio of 30%.